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Equine endothelial cells (EC) submitted to anoxia/reoxy-
genation (A/R) produce reactive oxygen species (ROS).INTRODUCTION
Endotheliumparticipates to the regulation of the inflamma-
tory response and ischemia/reperfusion-induced injuries
are suspected in laminitis. Herein, we investigated the effect
of anoxia/reoxygenation on ROS production by EC.
MATERIALS AND METHODS
EC cultures were obtained from equine carotid. Detached
cells (107) were submitted either to 3 cycles of 20min an-
oxia followed by reoxygenation in presence of POBN
(50mM)/ethanol (2%) mixture as spin trap or to 1h of
anoxia followed by reoxygenation and immediate addition
of 100mM DMPO. Normoxic cells were used as control
(n¼3). Anoxia and reoxygenation were monitored by
high-resolution respirometry and ROS production was
evidenced by electron paramagnetic resonance (EPR).RESULTS
After A/R cycles, high intensity EPR spectra, assigned to
the POBN/CH(OH)CH3 adducts were observed, but
not in normoxic cells (control). After 1h of anoxia followed
by reoxygenation, an enhanced production of DMPO-OH
adducts was observed compared to control.
DISCUSSION
The EPR spectra were consistent with the trapping of super-
oxide anionproducedbyEC.Suchaproduction couldderive
from either xanthine oxidase activity or mitochondria dys-
function. Production of ROS by EC could be involved in
the disruption of the endothelial barrier, the recruitment of
neutrophils and participate to the development of laminitis.CLINICAL RELEVANCE
Drugs (fractionated heparin or pentoxifylline) able to pro-
tect endothelium may have therapeutic relevance in pre-
venting laminitis.
CONCLUSION
ROS from EC submitted to A/R might play a crucial role
in the oxidative aspect of laminitis.Contractile Responses of Laminar
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Laminar veins are dysfunctional in horses with laminitis but
not those given LPS.
INTRODUCTION
The objective was to determine whether laminar and digital
vessels from horses with carbohydrate (CHO) or black wal-
nut heartwood extract (BWHE) -induced laminitis or from
horses infused with LPS possess basal tone.
MATERIALS & METHODS
24 horses were divided into 4 groups: 1) BWHE group (via
nasogastric tube); 2) CHO group (via nasogastric tube); 3)
LPS group (endotoxin, 30ng/kg, over 30min); or 4) Con-
trol Group (7L water via nasogastric tube). Horses were
euthanized at the following time points: BWHE or CHO
at the onset of Obel grade 1 laminitis; LPS and control
groups at 12h after LPS or water. Digital and laminar ar-
teries and veins were isolated to assess contractile function.
RESULTS
Laminar veins from horses given BWHE or CHO pos-
sessed basal tone (constricted when the bathing solution
was switched from 0mM Ca2þ to 2mM Ca2þ). Basal tone
was not attributable to capacitative or voltage-gated Ca2þ
entry, but was reversed by an inhibitor of Rho-kinase.
